Skip to Main Content
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase Research Catalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase Research Catalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Oncology CRO Services
Full Service CRO
Clinical Analytics
Site Network
Consulting
Development Phase
Early Phase ResearchCatalyst Oncology, an oncology clinical research organization, works with innovative biotechs on a range of early phase study designs and therapies.
Late Phase ResearchCatalyst Oncology helps move oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.
Information Sheet
Immuno-Oncology
Helping to bring immunotherapies to cancer patients in need
Read more
Insights
Contact Us
Category: Dose optimization
Executive Summary How Project Optimus Is Reshaping Oncology Development A panel of experts at BIO 2025 explored the transformative impact of Project Optimus, a Read Now Article Optimizing Global Early-phase Oncology Trials Strategies for Success  The clinical trial landscape is constantly evolving, particularly in oncology early development, Read Now Trends and Challenges Blog Series-Growing Complexity of Conducting Oncology Trials Blog The Growing Complexity of Conducting Oncology Trials Changing regulations, challenging study designs, and globalization Early-phase trial designs are becoming more complex following Read Now Patient meeting with doctor who is taking notes with sunshine coming in from the background. Blog Highlights from HubXchange Immunotherapies Maryland 2024 Optimizing dose and leveraging biomarkers for enhanced patient safety in immunotherapy trials HubXchange Immunotherapies brought Read Now
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.